×

CellRapeutics™ PBMC from Duchenne Muscular Dystrophy Donor (XS-0426-XL129)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Isolated from DMD donors, these PBMCs allow researchers to study the role of inflammation in muscle degeneration. They are ideal for profiling cytokine responses and T cell activity in neuromuscular disease.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ PBMC from Duchenne Muscular Dystrophy Donor
  • Cat. No.
  • XS-0426-XL129
  • Additional Donor Information
  • Donor metadata include confirmed Duchenne muscular dystrophy diagnosis, demographic profile, and allergy or infection history. Additional DMD-related clinical information may be available upon request.

Additional Information

  • Formulation
  • Frozen
  • Cell Purity
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Application
  • Drug Discovery, Immuno-oncology (IO) Research
  • Research Use Only
  • RUO
  • Storage
  • Upon arrival, immediately transfer the vial to the liquid nitrogen
  • Shiping
  • Dry Ice
  • Processing Time
  • Within 24 hours of blood collection.
  • Size
  • 5E6 cells/vial; 5E7 cells/vial; 2E9 cells/bulk vial
  • Keywords
  • Duchenne Muscular Dystrophy; PBMC

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ PBMC from Duchenne Muscular Dystrophy Donor (XS-0426-XL129). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.